Lipid nanoparticle-encapsulated DNA vaccine induces balanced antibody and T-cell responses in pigs with maternally derived antibodies
Journal of Virology · 2025
DOI: 10.1128/jvi.01123-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Danh C Lai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA. Hauptthemen laut MEDLINE: Vaccines, DNA, Antibodies, Viral, Nanoparticles, Orthomyxoviridae Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Food and Agriculture.
Abstract (Originalsprache)
Maternally derived antibodies (MDAs) play a vital role in protecting neonates from infectious diseases, but their presence at the time of vaccination can interfere with vaccine-induced immune responses, thereby reducing vaccine effectiveness. MDA interference has been documented in pigs vaccinated with whole-inactivated virus (WIV) vaccines against swine influenza A virus (IAV). This study evaluated the efficacy of a lipid nanoparticle-encapsulated DNA (LNP-DNA) vaccine against swine IAV in the presence and absence of MDAs, comparing it to a WIV vaccine. In MDA-negative piglets, both the LNP-DNA and WIV vaccines induced strong immune responses and effectively prevented the vaccinated animals from being infected with the homologous IAV strain. However, in MDA-positive piglets, the WIV vaccine failed to trigger significant antibody or T-cell responses and offered no protection against viral shedding or lung damage. In contrast, the LNP-DNA vaccine elicited stronger immune responses in MDA-positive pigs, reduced nasal viral shedding, and prevented lung lesions. These findings demonstrate that the LNP-DNA vaccine overcomes MDA interference, making it a promising strategy for enhancing vaccine efficacy in neonatal animals with maternal antibodies. IMPORTANCE Maternally derived antibody (MDA) interference is a major obstacle to developing effective vaccines for neonates. In pigs, MDAs significantly impair immune responses to a whole-inactivated virus vaccine. Here, we show that vaccination with a lipid nanoparticle (LNP)-encapsulated DNA vaccine can partially overcome MDA interference. These findings underscore the potential of the LNP-DNA vaccine as a viable strategy for effectively immunizing MDA-positive populations. Additionally, LNP-DNA vaccination in young pigs provides a valuable model for exploring the immunological mechanisms behind MDA-mediated suppression of vaccine-induced immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
- School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
- Department of Animal Science, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
ORCID-Profile: Danh C Lai, The N Nguyen, Hiep L X Vu
Förderung
- National Institute of Food and Agriculture
Zitieren
APA
Lai, D. C., Nguyen, T. N., Trinh, G. P., Steffen, D., & Vu, H. L. X. (2025). Lipid nanoparticle-encapsulated DNA vaccine induces balanced antibody and T-cell responses in pigs with maternally derived antibodies. Journal of Virology. https://doi.org/10.1128/jvi.01123-25
Vancouver
Lai DC, Nguyen TN, Trinh GP, Steffen D, Vu HLX. Lipid nanoparticle-encapsulated DNA vaccine induces balanced antibody and T-cell responses in pigs with maternally derived antibodies. Journal of Virology. 2025. doi:10.1128/jvi.01123-25
BibTeX
@article{Lai2025,
author = {Lai, Danh C and Nguyen, The N and Trinh, Giao P and Steffen, David and Vu, Hiep L X},
title = {Lipid nanoparticle-encapsulated DNA vaccine induces balanced antibody and T-cell responses in pigs with maternally derived antibodies},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.01123-25}
}
EUVIMED